Wang HY, Duan P, Chen H, Pan ZY. Unusual glomus tumor of the lower leg: A case report. World J Clin Cases 2022; 10(11): 3485-3489 [PMID: 35611196 DOI: 10.12998/wjcc.v10.i11.3485]
Corresponding Author of This Article
Zhen-Yu Pan, MD, PhD, Chief Physician, Professor, Department of Orthopedics, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuchang District, Wuhan 430000, Hubei Province, China. soloistp@126.com
Research Domain of This Article
Peripheral Vascular Disease
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Apr 16, 2022; 10(11): 3485-3489 Published online Apr 16, 2022. doi: 10.12998/wjcc.v10.i11.3485
Unusual glomus tumor of the lower leg: A case report
Han-Yu Wang, Ping Duan, Hui Chen, Zhen-Yu Pan
Han-Yu Wang, Ping Duan, Hui Chen, Zhen-Yu Pan, Department of Orthopedics, Zhongnan Hospital of Wuhan University, Wuhan 430000, Hubei Province, China
Author contributions: Pan ZY completed the operation and completed the revision of the manuscript; Wang HY and Duan P completed the follow-up and wrote the manuscript; and Chen H collected the data; all authors read and approved the final manuscript.
Informed consent statement: The patient agreed the doctors could use and publish her disease related article with personal information deleted.
Conflict-of-interest statement: The authors declare no conflict of interests.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhen-Yu Pan, MD, PhD, Chief Physician, Professor, Department of Orthopedics, Zhongnan Hospital of Wuhan University, No. 169 Donghu Road, Wuchang District, Wuhan 430000, Hubei Province, China. soloistp@126.com
Received: July 25, 2021 Peer-review started: July 25, 2021 First decision: October 25, 2021 Revised: November 4, 2021 Accepted: February 27, 2022 Article in press: February 27, 2022 Published online: April 16, 2022 Processing time: 257 Days and 1.4 Hours
Abstract
BACKGROUND
Glomus tumors are rare neoplasms, usually found on the fingers or toes. Glomus tumours that occur in the lower leg are even rarer and is likely to be misdiagnosed or underdiagnosed. This article will document the diagnosis, treatment, and follow-up of a rare glomus tumor of the lower leg, which had been misdiagnosed for up to 15 years.
CASE SUMMARY
The patient was a A 36-year-old woman who had suffered from localized pain in her left lower leg for 15 years. After a complete physical examination, a glomus tumor on her lower leg was considered and removed surgically. The specimen was pathologically diagnosed as a glomus tumor. There was no relapse at a 4-year follow-up.
CONCLUSION
Correct diagnosis and complete removal of the glomus tumor is important.
Core Tip: A 36-year-old woman who had suffered from localized pain in her left lower leg had been misdiagnosed for up to 15 years. She was eventually diagnosed with glomus tumor and underwent surgical treatment. The patient recovered well with no recurrence observed at a 4-year follow-up.